Personalized Medicine Market Size, Share, Growth Report 2032

Personalized Medicine Market

Personalized Medicine Market By Therapeutic Area (Oncology, Neurology, Cardiology, Antiviral, Psychiatry, And Others), By Application (Companion Diagnostics, Health Informatics, Biomarker Identification, And Clinical Research Applications), By End-User (Hospitals, Molecular Diagnostic Laboratories And Testing Facilities, Academic Institutes, Clinical Care And Research Laboratories, Contract Research Organizations, Bio And Health Informatics Companies, And Others), By Technology (Pharmacogenomics, Metabolomics, Pharmacoproteomics, Pharmacogenetics, Stem Cell Therapy, Pharmacodynamics, Point Of Care, And Pharmacokinetics), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2024–2032

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-3583 Published Date: Apr-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 563.02 Million USD 1,048.22 Million 7.15% 2023

Table Of Content

  • Chapter 1. Introduction
    • 1.1. Report description and scope
    • 1.2. Research scope
    • 1.3. Research methodology
      • 1.3.1. Market research process
      • 1.3.2. Market research methodology
  •  
  • Chapter 2. Executive Summary
    • 2.1. Global Personalized Medicine Market, 2024 - 2032 (USD Million)
    • 2.2. Global Personalized Medicine Market: Snapshot
  •  
  • Chapter 3. Personalized medicine Market - Dynamics
    • 3.1. Introduction
    • 3.2. Market drivers
      • 3.2.1. Global Personalized medicine market drivers: Impact analysis
      • 3.2.2. Increase in the disease incidence
      • 3.2.3. Highly effective, safe and fast results
    • 3.3. Market Restraints
      • 3.3.1. Global Personalized medicine market restraints: Impact analysis
      • 3.3.2. Complex nature of drugs
      • 3.3.3. High developmental cost
    • 3.4. Opportunities
      • 3.4.1. Favorable Government policies
      • 3.4.2. Recent developments create a suitable environment for drug development
    • 3.5. Porter's Five Forces Analysis
      • 3.5.1. Bargaining power of suppliers
      • 3.5.2. Bargaining power of buyers
      • 3.5.3. The threat from new entrants
      • 3.5.4. The threat from new substitutes
      • 3.5.5. Degree of competition
    • 3.6. Market attractiveness analysis
      • 3.6.1. Market attractiveness analysis, by Therapeutic area segment
      • 3.6.2. Market attractiveness analysis, by Application Segment
      • 3.6.3. Market attractiveness analysis, by Technology segment
      • 3.6.4. Market attractiveness analysis, by End-User segment
      • 3.6.5. Market attractiveness analysis, by regional segment
  •  
  • Chapter 4. Global Personalized medicine Market - Competitive Landscape
    • 4.1. Company Market Share Analysis
      • 4.1.1. Global Personalized Medicine Market: company market share, 2024
    • 4.2. Strategic Development
      • 4.2.1. Acquisitions & Mergers
      • 4.2.2. New Launch
      • 4.2.3. Agreements, Partnerships, Collaborations and Joint Ventures
      • 4.2.4. R&D
      • 4.2.5. Regional Expansion
    • 4.3. Price Trend Analysis
    • 4.4. Technology Portfolio
  •  
  • Chapter 5. Global Personalized medicine Market - Therapeutic Area Segment Analysis
    • 5.1. Global Personalized Medicine Market: Therapeutic Area overview
      • 5.1.1. Global Personalized medicine market revenue share, by Therapeutic Area, 2024 and 2032
    • 5.2. Oncology
  •  
  • Chapter 6. Global Oncology Market, 2024 - 2032 (USD Million)
    • 6.1. Neurology
      • 6.1.1. Global Neurology Market, 2024 - 2032(USD Million)
    • 6.2. Cardiology
      • 6.2.1. Global Cardiology Market, 2024 - 2032(USD Million)
    • 6.3. Antiviral
      • 6.3.1. Global Antiviral Market, 2024 - 2032(USD Million)
    • 6.4. Psychiatry
      • 6.4.1. Global Psychiatry Market, 2024 - 2032 (USD Million)
    • 6.5. Others
      • 6.5.1. Global Others market, 2024 - 2032 (USD Million)
  •  
  • Chapter 7. Global Personalized medicine Market - Application Segment Analysis
    • 7.1. Global Personalized medicine: Application overview
      • 7.1.1. Global Personalized medicine Market revenue share, by Application, 2024 and 2032
    • 7.2. Companion Diagnostics
      • 7.2.1. Global Companion Diagnostics Market, 2024 - 2032 (USD Million)
    • 7.3. Health Informatics
      • 7.3.1. Global Health Informatics Market,2024 - 2032(USD Million)
    • 7.4. Biomarker Identification
      • 7.4.1. Global Biomarker Identification Market, 2024 - 2032(USD Million)
    • 7.5. Clinical Research
      • 7.5.1. Global Clinical Research Market, 2024 - 2032(USD Million)
  •  
  • Chapter 8. Global Personalized medicine Market - Technology Segment Analysis
    • 8.1. Global Personalized medicine market: Technology overview
      • 8.1.1. Global Personalized medicine market revenue share, by Technology, 2024 and 2032
    • 8.2. Pharmacogenomics
      • 8.2.1. Global Pharmacogenomics Market, 2024 - 2032(USD Million)
    • 8.3. Metabolomics
      • 8.3.1. Global Metabolomics Market, 2024 - 2032(USD Million)
    • 8.4. Pharmacoproteomics
      • 8.4.1. Global Pharmacoproteomics Market, 2024 -2032(USD Million)
    • 8.5. Stem Cell Therapy
      • 8.5.1. Global Stem Cell Therapy Market, 2024 - 2032(USD Million)
    • 8.6. Pharmacodynamics
      • 8.6.1. Global Pharmacodynamics market, 2024 - 2032 (USD Million)
    • 8.7. Point of care
      • 8.7.1. Global Point of Care Market, 2024 - 2032 (USD Million)
    • 8.8. Pharmacokinetics
      • 8.8.1. Global Pharmacokinetics Market, 2024 - 2032 (USD Million)
  •  
  • Chapter 9. Global Personalized medicine Market - End-User Segment Analysis
    • 9.1. Global Personalized Medicine Market: End-User segment overview
      • 9.1.1. Global Personalized medicine Market revenue share, by End-User, 2024 and 2032
    • 9.2. Hospitals
      • 9.2.1. Global Hospitals Market, 2024 - 2032(USD Million)
    • 9.3. Molecular diagnostic laboratories and testing facilities
      • 9.3.1. Global Molecular diagnostic laboratories and testing facilities Market, 2024 - 2032(USD Million)
    • 9.4. Academic institutes, Clinical care, and research laboratories
      • 9.4.1. Global Academic institutes, Clinical care, and research laboratories Market, 2024 - 2032(USD Million)
    • 9.5. Contract Research organization
      • 9.5.1. Global contract research Organization Market, 2024 - 2032 (USD Million)
    • 9.6. Bio and health informatics companies
      • 9.6.1. Global Bio and health informatics companies Market, 2024 - 2032 (USD Million)
    • 9.7. Others
      • 9.7.1. Global Others Market, 2024 - 2032 (USD Million)
  •  
  • Chapter 10. Global Personalized medicine Market - Regional Segment Analysis
    • 10.1. Global Personalized Medicine Market: Regional overview
      • 10.1.1. Global Personalized medicine Market revenue share, by region, 2024 and 2032
    • 10.2. North America
      • 10.2.1. North America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
      • 10.2.2. North America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.2.3. North America Personalized medicine market revenue, by Application, 2024 - 2032 (USD Million)
      • 10.2.4. The U.S.
        • 10.2.4.1. The U.S. Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
        • 10.2.4.2. The U.S. Personalized medicine market revenue, by Application, 2024 - 2032 (USD Million)
        • 10.2.4.3. The U.S. Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.2.4.4. The U.S. Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
      • 10.2.5. Rest of North America
        • 10.2.5.1. Rest of North America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.2.5.2. Rest of North America Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.2.5.3. Rest of North America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.2.5.4. Rest of North America Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
    • 10.3. Europe
      • 10.3.1. Europe Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
      • 10.3.2. Europe Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.3.3. Europe Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million)
      • 10.3.4. Europe Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
      • 10.3.5. Germany
        • 10.3.5.1. Germany Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.3.5.2. Germany Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.3.5.3. Germany Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million)
        • 10.3.5.4. Germany Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
      • 10.3.6. France
        • 10.3.6.1. France Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.3.6.2. France Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.3.6.3. France Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.3.6.4. France Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
      • 10.3.7. UK
        • 10.3.7.1. UK Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.3.7.2. UK Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.3.7.3. UK Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.3.7.4. UK Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
      • 10.3.8. Rest of Europe
        • 10.3.8.1. Rest of Europe Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.3.8.2. Rest of Europe Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.3.8.3. Rest of Europe Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.3.8.4. Rest of Europe Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
    • 10.4. Asia Pacific
      • 10.4.1. Asia Pacific Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032, (USD Million)
      • 10.4.2. Asia Pacific Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.4.3. Asia Pacific Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.4.4. Asia Pacific Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
      • 10.4.5. China
        • 10.4.5.1. China Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
        • 10.4.5.2. China Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.4.5.3. China Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.4.5.4. China Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
      • 10.4.6. Japan
        • 10.4.6.1. Japan Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.4.6.2. Japan Personalized medicine market revenue, by Application, 2024 - 2032 (USD Million)
        • 10.4.6.3. Japan Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.4.6.4. Japan Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
      • 10.4.7. India
        • 10.4.7.1. India Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.4.7.2. India Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.4.7.3. India Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.4.7.4. India Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
      • 10.4.8. Rest of Asia Pacific
        • 10.4.8.1. Rest of Asia Pacific Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.4.8.2. Rest of Asia Pacific Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.4.8.3. Rest of Asia Pacific Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.4.8.4. Rest of Asia Pacific Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
    • 10.5. Latin America
      • 10.5.1. Latin America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032, (USD Million)
      • 10.5.2. Latin America Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.5.3. Latin America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.5.4. Latin America Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
      • 10.5.5. Brazil
        • 10.5.5.1. Brazil Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.5.5.2. Brazil Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.5.5.3. Brazil Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.5.5.4. Brazil Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
      • 10.5.6. Rest of Latin America
        • 10.5.6.1. Rest of Latin America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
        • 10.5.6.2. Rest of Latin America Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
        • 10.5.6.3. Rest of Latin America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
        • 10.5.6.4. Rest of Latin America Personalized medicine market revenue, by End-User, 2024 - 2032(USD Million)
    • 10.6. The Middle East and Africa
      • 10.6.1. The Middle East and Africa Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032, (USD Million)
      • 10.6.2. The Middle East and Africa Personalized medicine market revenue, by Application, 2024 - 2032(USD Million)
      • 10.6.3. The Middle East and Africa Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
      • 10.6.4. The Middle East and Africa Personalized medicine market revenue, by End-User, 2024 - 2032 (USD Million)
  •  
  • Chapter 11. Company Profile
    • 11.1. F. Hoffmann-La Roche Ltd.
      • 11.1.1. Overview
      • 11.1.2. Financials
      • 11.1.3. Therapeutic Area portfolio
      • 11.1.4. Business strategy
      • 11.1.5. Recent developments
    • 11.2. Pfizer Inc.
      • 11.2.1. Overview
      • 11.2.2. Financials
      • 11.2.3. Therapeutic Area portfolio
      • 11.2.4. Business strategy
      • 11.2.5. Recent developments
    • 11.3. Qiagen
      • 11.3.1. Overview
      • 11.3.2. Financials
      • 11.3.3. Therapeutic Area portfolio
      • 11.3.4. Business strategy
      • 11.3.5. Recent developments
    • 11.4. AstraZeneca Plc.
      • 11.4.1. Overview
      • 11.4.2. Financials
      • 11.4.3. Therapeutic Area portfolio
      • 11.4.4. Business strategy
      • 11.4.5. Recent developments
    • 11.5. Merck & Co., Inc.
      • 11.5.1. Overview
      • 11.5.2. Financials
      • 11.5.3. Therapeutic Area portfolio
      • 11.5.4. Business strategy
      • 11.5.5. Recent developments
    • 11.6. Siemens Healthcare GmbH
      • 11.6.1. Overview
      • 11.6.2. Financials
      • 11.6.3. Therapeutic Area portfolio
      • 11.6.4. Business strategy
      • 11.6.5. Recent developments
    • 11.7. Vertex Pharmaceuticals Incorporated
      • 11.7.1. Overview
      • 11.7.2. Financials
      • 11.7.3. Therapeutic Area portfolio
      • 11.7.4. Business strategy
      • 11.7.5. Recent developments
    • 11.8. Becton, Dickinson and Company
      • 11.8.1. Overview
      • 11.8.2. Financials
      • 11.8.3. Therapeutic Area portfolio
      • 11.8.4. Business strategy
      • 11.8.5. Recent developments

Table Of Figures

List of Figures 

1. Market research process
2. Market research methodology
3. Global Personalized medicine market revenue, 2024 - 2032 (USD Million) 
4. Porter’s Five Forces Analysis
5. Personalized medicine market attractiveness analysis, by Therapeutic Area segment
6. Personalized Medicine Market: Market attractiveness analysis, by Application Segment
7. Personalized medicine market: Market attractiveness analysis, by Technology segment
8. Personalized medicine market: Market attractiveness analysis, by End-User segment
9. Personalized Medicine Market: Market attractiveness analysis, by Regional segment
10. Company market share analysis, 2024
11. Global Personalized medicine market revenue share by Therapeutic Area, 2024 and 2032
12. Global Oncology market, 2024 - 2032 (USD Million)
13. Global Neurology market, 2024 - 2032 (USD Million)
14. Global Cardiology market, 2024 - 2032 (USD Million)
15. Global Antiviral market, 2024 - 2032 (USD Million)
16. Global Psychiatry market, 2024 - 2032 (USD Million)
17. Global Others Market, 2024 - 2032 (USD Million)
18. Global Competitive Personalized medicine, 2024 - 2032 (USD Million)
19. Global Personalized medicine market revenue share by Application, 2024 and 2032
20. Global Companion diagnostics market, 2024 - 2032 (USD Million) 
21. Global Health informatics market, 2024 - 2032 (USD Million) 
22. Global Health informatics market, 2024 - 2032 (USD Million)
23. Global Clinical research market, 2024 - 2032 (USD Million)
24. Global Personalized medicine market revenue share by Technology, 2024 and 2032
25. Global Pharmacogenomics market, 2024 - 2032 (USD Million)
26. Global Metabolomics market, 2024 - 2032 (USD Million)
27. Global Pharmacoproteomics market, 2024 - 2032 (USD Million)
28. Global Pharmacogenetics market, 2024 - 2032 (USD Million)
29. Global Stem cell therapy market, 2024 - 2032 (USD Million)
30. Global Pharmacodynamics market, 2024 - 2032 (USD Million)
31. Global Point of care market, 2024 - 2032 (USD Million)
32. Global Pharmacokinetics market, 2024 - 2032 (USD Million)
33. Global Personalized medicine market revenue share by End-User, 2024 and 2032
34. Global Hospitals market, 2024 - 2032 (USD Million)
35. Global Molecular diagnostic laboratories and testing facilities market, 2024 – 2032 (USD Million)
36. Global Academic institutes, Clinical care and research laboratories market, 2024 – 2032 (USD Million)
37. Global Contract research organization market, 2024 – 2032 (USD Million)
38. Global Bio and health informatics companies market, 2024 – 2032 (USD Million)
39. Global Others market, 2024 – 2032 (USD Million)


Table Of Tables

List of Tables

1.    Personalized medicine: Market Snapshot
2.    Drivers of global Personalized medicine market: Impact analysis 
3.    Restraints of global Personalized medicine market: Impact analysis 
4.    North America Personalized medicine market revenue, by Therapeutic Area, 2024 – 2032 (USD Million) 
5.    North America Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
6.    North America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
7.    North America Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million)
8.    The U.S. Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
9.    The U.S. Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
10.    The U.S. Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
11.    The U.S. Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million)
12. Rest of North America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
13.    Rest of North America Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
14.    Rest of North America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
15.    Rest of North America Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million)
16.    Europe personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
17. Europe Personalized medicine revenue, by Application, 2024 - 2032 (USD Million)
18.    Europe Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million)
19.    Europe Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
20.    U.K. personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
21.    U.K. Personalized medicine revenue, by Application, 2024 - 2032 (USD Million)
22.    U.K. Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
23.    U.K. Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
24.    Germany personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million)
25.    Germany Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
26.    Germany Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
27.    Germany Personalized medicine market revenue, by End-User type, 2024 - 2032(USD Million) 
28. France personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million)
29. France Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
30.    France Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
31.    France Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
32.    Rest of Europe Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million) 
33.    Rest of Europe Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
34.    Rest of Europe Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
35.    Rest of Europe Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
36.    Asia Pacific Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million) 
37.    Asia Pacific Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
38.    Asia Pacific Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
39.    Asia Pacific Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
40.    China Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
41.    China Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
42.    China Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
43.    China Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
44.    Japan Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032(USD Million) 
45.    Japan Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
46.    Japan Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
47.    Japan Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
48.    India Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
49.    India Personalized medicine revenue, by Application, 2024 – 2032 (USD Million)
50.    India Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
51.    India Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
52. Rest of Asia Pacific Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
53.    Rest of Asia Pacific Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
54.    Rest of Asia Pacific Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
55.    Rest of Asia Pacific Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
56. Latin America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
57.    Latin America Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
58.    Latin America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
59.    Latin America Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
60. Brazil Personalized medicine market revenue, by Therapeutic Area, 2024 – 2032 (USD Million) 
61.    Brazil Personalized medicine revenue, by Application, 2024 - 2032(USD Million) 
62.    Brazil Personalized medicine market revenue, by Technology, 2024 - 2032(USD Million) 
63.    Brazil Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million) 
64. Rest of Latin America Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
65.    Rest of Latin America Personalized medicine revenue, by Application, 2024 - 2032 (USD Million) 
66.    Rest of Latin America Personalized medicine market revenue, by Technology, 2024 - 2032 (USD Million) 
67.    Rest of Latin America Personalized medicine market revenue, by End-User type, 2024 - 2032(USD Million) 
68. The Middle East and Africa Personalized medicine market revenue, by Therapeutic Area, 2024 - 2032 (USD Million) 
69.    The Middle East and Africa Personalized medicine revenue, by Application, 2024 – 2032 (USD Million) 
70.    The Middle East and Africa Personalized medicine market revenue, by Technology, 2024 – 2032 (USD Million) 
71.    The Middle East and Africa Personalized medicine market revenue, by End-User type, 2024 - 2032 (USD Million)

Methodology

FrequentlyAsked Questions

Personalized medicine is tailored medical treatment for individual patients or intended patient groups with a similar biomarker.

According to study, the global personalized medicine market size was worth around USD 563.02 million in 2023 and is predicted to grow to around USD 1,048.22 million by 2032.

The CAGR value of personalized medicine market is expected to be around 7.15% during 2024-2032.

North America has been leading the global personalized medicine market and is anticipated to continue on the dominant position in the years to come.

The global personalized medicine market is led by players like F. Hoffmann-La Roche Ltd., Pfizer Inc., Qiagen, AstraZeneca Plc., Merck & Co., Inc., Siemens Healthcare GmbH, Vertex Pharmaceuticals Incorporated, and Becton, Dickinson Company, and among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed